Drudge J H, Lyons E T, Tolliver S C
Am J Vet Res. 1980 Sep;41(9):1383-7.
The basic-dose confirmation tests of tioxidazole for removal of susceptible populations of gastrointestinal parasites of the horse were made in 10 naturally infected horses, using the critical test method (experiment A). A single dose of toxidazole, given at the rate of 11 mg/kg of body weight, was administered to 5 horses by stomach tube and to 5 horses by mixing the drug with the daily grain ration. In the 5 horses given the drug by stomach tube, aggregate average removals were 90% or more for 5 horses infected with Stronglyus vulgaris, 5 infected with S edentatus, 5 infected with small strongyles, 3 infected with Parascaris equorum, 3 infected with mature Oxyuris equi, and 5 infected with immature O equi. Bots (Gastrophilus intestinalis and G nasalis) in 5 infected horses and tapeworms (Anoplocephala perfoliata or A magna) in 3 infected horses were not removed. Activity against stomach worms (Trichostrongylus axei, Habronema muscae, and Drashia megastoma) was not evidenced. In the 5 horses given the drug in the feed, aggregate average removals were 90% or more for 5 horses infected with S vulgaris, 5 infected with S edentatus, 1 infected with S equinus, 5 infected with small strongyles, 3 infected with P equorum, 3 infected with mature O equi, and 5 infected with immature O equi. Activity against bots, tapeworms, and stomach worms was not detected. Larval count data on fecal samples also indicated liited, if any, activity against Strongyloides westeri by tioxidazole at this dosage (11 mg/kg). In addition to experiment A, tioxidazole (11 mg/kg) was administered via stomach tube in a single dose in a critical test to a foal naturally infected with benzimidazole-resistant small strongyles (population B) and removal was only 27% (experiment B). The same 5 species of small strongyles refractory to the benzimidazoles also exhibited resistance to tioxidazole. Specimens of P equorum and S vulgaris were all removed from the foal. Untoward effects of tioxidazole treatment (11 mg/kg) were not observed in any of the animals.
采用临界试验方法(实验A),对10匹自然感染胃肠道寄生虫的马进行了噻苯达唑基础剂量确认试验。以11毫克/千克体重的剂量,给5匹马通过胃管投予单剂量噻苯达唑,给另外5匹马将药物与每日谷物日粮混合投喂。在通过胃管给药的5匹马中,对于感染普通圆线虫的5匹马、感染无齿圆线虫的5匹马、感染小型圆线虫的5匹马、感染马副蛔虫的3匹马、感染成熟马尖尾线虫的3匹马以及感染未成熟马尖尾线虫的5匹马,总体平均清除率达到90%或更高。5匹感染马胃蝇(肠胃蝇和鼻胃蝇)和3匹感染绦虫(叶状裸头绦虫或大裸头绦虫)的马未被清除。未证实对胃线虫(艾氏毛圆线虫、蝇柔线虫和大口德拉西线虫)有活性。在通过饲料给药的5匹马中,对于感染普通圆线虫的5匹马、感染无齿圆线虫的5匹马、感染马圆线虫的1匹马、感染小型圆线虫的5匹马、感染马副蛔虫的3匹马、感染成熟马尖尾线虫的3匹马以及感染未成熟马尖尾线虫的5匹马,总体平均清除率达到90%或更高。未检测到对马胃蝇、绦虫和胃线虫的活性。粪便样本的幼虫计数数据也表明,在此剂量(11毫克/千克)下,噻苯达唑对韦氏类圆线虫的活性有限(如果有活性的话)。除了实验A,在一项临界试验中,给一匹自然感染对苯并咪唑耐药的小型圆线虫(群体B)的幼驹通过胃管单剂量投予噻苯达唑(11毫克/千克),清除率仅为27%(实验B)。同样对苯并咪唑耐药的5种小型圆线虫对噻苯达唑也表现出耐药性。马副蛔虫和普通圆线虫的样本均从幼驹体内清除。在任何动物中均未观察到噻苯达唑治疗(11毫克/千克)的不良影响。